The DNA methyltransferase inhibitor zebularine exerts antitumor effects and reveal BATF2 as a poor prognostic marker for childhood medulloblastoma (2017)
- Authors:
- USP affiliated authors: SERAFINI, LUCIANO NEDER - FMRP ; SCRIDELI, CARLOS ALBERTO - FMRP ; TONE, LUIZ GONZAGA - FMRP
- Unidade: FMRP
- DOI: 10.1007/s10637-016-0401-4
- Subjects: EPIGÊNESE GENÉTICA; MEDULOBLASTOMA; ANTINEOPLÁSICOS
- Keywords: Medulloblastoma; Zebularine; Epigenetics; DNA methyltransferases
- Language: Inglês
- Imprenta:
- Source:
- Título do periódico: Investigational New Drugs
- ISSN: 0167-6997
- Volume/Número/Paginação/Ano: v. 35, n. 1, p. 26-36, 2017
- Este periódico é de assinatura
- Este artigo NÃO é de acesso aberto
- Cor do Acesso Aberto: closed
-
ABNT
ANDRADE, Augusto Faria et al. The DNA methyltransferase inhibitor zebularine exerts antitumor effects and reveal BATF2 as a poor prognostic marker for childhood medulloblastoma. Investigational New Drugs, v. 35, n. 1, p. 26-36, 2017Tradução . . Disponível em: https://doi.org/10.1007/s10637-016-0401-4. Acesso em: 26 abr. 2024. -
APA
Andrade, A. F., Borges, K. S., Suazo, V. K., Geron, L., Corrêa, C. A. P., Castro-Gamero, A. M., et al. (2017). The DNA methyltransferase inhibitor zebularine exerts antitumor effects and reveal BATF2 as a poor prognostic marker for childhood medulloblastoma. Investigational New Drugs, 35( 1), 26-36. doi:10.1007/s10637-016-0401-4 -
NLM
Andrade AF, Borges KS, Suazo VK, Geron L, Corrêa CAP, Castro-Gamero AM, Vasconcelos EJR de, Oliveira RS de, Neder L, Yunes JA, Aguiar S dos S, Scrideli CA, Tone LG. The DNA methyltransferase inhibitor zebularine exerts antitumor effects and reveal BATF2 as a poor prognostic marker for childhood medulloblastoma [Internet]. Investigational New Drugs. 2017 ; 35( 1): 26-36.[citado 2024 abr. 26 ] Available from: https://doi.org/10.1007/s10637-016-0401-4 -
Vancouver
Andrade AF, Borges KS, Suazo VK, Geron L, Corrêa CAP, Castro-Gamero AM, Vasconcelos EJR de, Oliveira RS de, Neder L, Yunes JA, Aguiar S dos S, Scrideli CA, Tone LG. The DNA methyltransferase inhibitor zebularine exerts antitumor effects and reveal BATF2 as a poor prognostic marker for childhood medulloblastoma [Internet]. Investigational New Drugs. 2017 ; 35( 1): 26-36.[citado 2024 abr. 26 ] Available from: https://doi.org/10.1007/s10637-016-0401-4 - Cytogenetic findings in pediatric radiation-induced atypical meningioma after treatment of medulloblastoma: case report and review of the literature
- H1F1A is overexpressed in medulloblastomas and its inhibition is able in reduce proliferation and increase HIF2A and ATG16L1 methylation levels in a cell line model
- Erratum to: The DNA methyltransferase inhibitor zebularine exerts antitumor effects and reveals BATF2 as a poor prognostic marker for childhood medulloblastoma
- Prognostic impact of the expression profile of the hypoxia related genes CA9, CA12, HIF2A, SCL2A1 and VEGF in osteosarcoma and ewing sarcoma
- Differential miRNA expression in medulloblastomas, fetal and non-fetal non neoplastic cerebellum. Identification of potential prognostic markers
- Inibição do crescimento e redução da capacidade clonogênica em linhagens celulares de glioblastomas pediátricos e adultos através do DHMEQ
- Acute lymphoblastic leukemia analyzed by comparative genome hybridization(CGH)
- mRNA expression profile of multidrug resistance genes in childhood acute lymphoblastic leukemia, low expression levels associated with a higher risk of toxic death
- microRNA expression in childhood acute lymphoblastic leukemia: identification of microRNAs involved in leukemogenesis and prognosis
- Decreased expression of BATF2 is significantly associatedwith poor prognosis in childhood medulloblastoma
Informações sobre o DOI: 10.1007/s10637-016-0401-4 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
